News
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
Cheaper alternatives to Ozempic and Wegovy may disappear as FDA reconsiders compounded drug loophole
SHREVEPORT, La. - Many people are using cheaper versions of popular weight-loss shots like Ozempic and Wegovy.
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.
Ozempic is an injectable semaglutide medication approved by the Food and Drug Administration (FDA) to help manage type 2 diabetes and assist in blood sugar management, alongside lifestyle changes.
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results